What is the ITH?
The IUIS Immunotherapy Committee (ITH) has been created to assist in the development and clinical application of immunotherapy in the treatment of cancer and infectious diseases with special emphasis on the developing world.
- Develop policy positions on the application of new immune therapy approaches in cancer and infectious diseases
- Communication with other organizations devoted the supporting immunotherapy (i.e. SITC; joint projects)
- Sponsor public and academic education on immune therapy issues
Listen to a BBC5 radio interview on T-cell related discoveries:
The 2022 #ThankYouImmunology campaign will play out on social media on the four days leading…
Back to Committees